指南与共识关节外科脊柱外科运动医学

骨科感染国际共识会议:ICM 2018与ICM 2025推荐意见的差异比较

International Consensus Meeting on Orthopaedic Infection: Differences Between ICM 2018 and ICM 2025.
指南 / 共识 · J Arthroplasty · 2025-11-04

该研究比较2018年与2025年骨科感染国际共识会议(ICM)的推荐意见,共识别172个可比问题,覆盖一般、生物膜、髋膝、肩及脊柱等主题领域。结果显示37个问题(21.5%)的推荐意见发生变化,2025年有33个问题(19.2%)获得更强证据支持,42个问题(24.4%)证据支持变弱。2025年ICM采用更直接的措辞并明确标注证据等级与共识强度。

要点

  • 172个可比问题中,37个(21.5%)推荐意见在2025年ICM发生变化。
  • 2025年33个问题(19.2%)证据支持增强,42个问题(24.4%)证据支持减弱。
  • 2025年ICM采用更直接措辞并明确标注证据等级与共识强度。

核心结论

  • 高质量证据的快速产生改变了共识推荐意见,凸显ICM在统一全球实践和确定PJI管理研究优先方向中的核心作用。

研究设计与样本

  • 比较2018年与2025年ICM推荐意见的研究,共识别172个覆盖一般、生物膜、髋膝、肩及脊柱等主题领域的可比问题。

主要发现

  • 172个可比问题中,37个问题(21.5%)的推荐意见发生变化。
  • 2025年有33个问题(19.2%)获得更强证据支持,42个问题(24.4%)证据支持变弱。
  • 重要演变包括:认识到既往同侧关节镜术后行全膝关节置换术(TKA)翻修风险增加;确立急性PJI行清创、抗生素和植入物保留(DAIR)后至少12周抗生素方案;更新重复DAIR手术作用的指导。
  • 2025年ICM采用更直接的措辞并明确标注证据等级与共识强度,提供更清晰的临床指导。

关键数值与推荐

  • 推荐意见变化的问题数为37/172(21.5%)。
  • 2025年证据支持更强的问题数为33/172(19.2%),证据支持更弱的问题数为42/172(24.4%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection (PJI) remains one of the most devastating complications after total joint arthroplasty. The International Consensus Meeting (ICM) has emerged as the leading global initiative to provide evidence-based recommendations on the prevention, diagnosis, and management of PJI. This study compares the recommendations of the 2018 and 2025 ICMs to assess how evolving evidence has shaped clinical guidance. METHODS: A total of 172 comparable questions were identified across thematic areas, including general, biofilm, hip and knee, shoulder, and spine. RESULTS: Changes in recommendations were observed in 37 questions (21.5%), while 33 (19.2%) were supported by stronger evidence in 2025 and 42 (24.4%) by weaker evidence. Notable evolution included recognition of the increased revision risk following total knee arthroplasty (TKA) after prior ipsilateral arthroscopy, the establishment of a minimum 12-week antibiotic regimen after debridement, antibiotics, and implant retention (DAIR) for acute PJI, and updated guidance on the role of repeat DAIR procedures. Beyond content, the 2025 ICM adopted more directive language with explicit grading of evidence and consensus strength, providing clearer clinical guidance. CONCLUSIONS: These findings highlight how the rapid generation of high-quality evidence has transformed consensus recommendations, underscoring the central role of ICM in harmonizing global practice and defining research priorities in the management of PJI.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ferrini A, He M, Bernaus M, et al. International Consensus Meeting on Orthopaedic Infection: Differences Between ICM 2018 and ICM 2025. J Arthroplasty. 2025. PMID: 41192529. doi:10.1016/j.arth.2025.10.113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。